Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Hepatitis A Vaccine in IBD Patients
NCT01341808Phase 4Completed
- Sponsor
- Asan Medical Center
- Start
- Apr 2011
- Primary completion
- Feb 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Epaxal Junior in hepatitis A (HAV), sponsored by Asan Medical Center. Started Apr 2011; status: completed.
02
Drugs
Epaxal Junior
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT01341808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01341808.